Nascent Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021
November 04, 2021 at 04:10 pm EDT
Nascent Biotech, Inc. reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported net loss was USD 0.21103 million compared to USD 0.418294 million a year ago.
For the six months, net loss was USD 0.661106 million compared to USD 0.622265 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.